Log in to save to my catalogue

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_35375ab8c6b047b3ab177e55c89f6e53

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan

About this item

Full title

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan

Publisher

Basel: MDPI AG

Journal title

International journal of neonatal screening, 2021-09, Vol.7 (3), p.45

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes degeneration of anterior horn cells in the human spinal cord and subsequent loss of motor neurons. The severe form of SMA is among the genetic diseases with the highest infant mortality. Although SMA has been considered incurable, newly developed drugs—nusinersen and onas...

Alternative Titles

Full title

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_35375ab8c6b047b3ab177e55c89f6e53

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_35375ab8c6b047b3ab177e55c89f6e53

Other Identifiers

ISSN

2409-515X

E-ISSN

2409-515X

DOI

10.3390/ijns7030045

How to access this item